Remove Manufacturing Remove Networking Remove Pharmaceutical manufacturing Remove Safety
article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Importantly, each site features advanced technologies to support development and manufacture of these therapeutics. Materials and financing costs are high and squeezing manufacturers and their customers alike.

article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

The companies offer various products and services for diverse operations including, but not limited to, consulting, clinical, medical affairs, regulatory affairs, analytics, safety, marketing, and customer experience.

Leads 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Leading pharmaceutical logistics and pharma supply chain companies

Pharmaceutical Technology

The pharmaceutical supply chain is a global and complex network that includes a wide range of stakeholders such as pharmaceutical manufacturers, wholesale distributors, and pharmacy benefit managers (PBM), to ensure efficient and timely delivery of medications to the patients.

article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

Driven by predictive analytics and machine learning, ACT ICS PRM allows manufacturers to rapidly identify patient behaviors and patterns to develop personas and predict the “next best action” for personalized engagement. Pharma Manufacturer Solutions. GM of Manufacturer Solutions. Aaron Crittenden. acrittenden@goodrx.com.

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We The non-profit B Labs issues B Corp certifications to businesses that can demonstrate a positive social and environmental impact, as well as make certain public commitments to accountability and transparency.

article thumbnail

Tackling fake pharmaceuticals: an industry united against counterfeit products

European Pharmaceutical Review

To appreciate the scope of the challenge facing the pharmaceutical market, as well as patients across the globe, we must understand that there are two distinct threats – ‘counterfeit’ and ‘falsified’ medicines. These may be mislabelled or produced in fake packaging and, most dangerously, there is no regulation around their manufacture.